Nasopharyngeal Cancer Clinical Trials

• Combination Chemotherapy in Treating Patients With Stage IIB, Stage III, or Stage IV Cancer of the Nasopharynx
  ClinicalTrials.gov Identifier: NCT00004164 - Active, not recruiting
  stage II nasopharyngeal cancer; stage III nasopharyngeal cancer; stage IV nasopharyngeal cancer
  
• Chemotherapy and Radiation Therapy in Treating Patients With Advanced Cancer of the Nasopharynx
  ClinicalTrials.gov Identifier: NCT00002999 - Active, not recruiting
  stage III nasopharyngeal cancer; stage IV nasopharyngeal cancer
  
• Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Cancer of the Nasopharynx
  ClinicalTrials.gov Identifier: NCT00025298 - Active, not recruiting
  stage II nasopharyngeal cancer; stage III nasopharyngeal cancer; stage IV nasopharyngeal cancer; oral complications of cancer and cancer therapy; ...
  
• Vaccine Therapy in Treating Patients With Nasopharyngeal Cancer at High Risk for Recurrence After Standard Therapy
  ClinicalTrials.gov Identifier: NCT00112541 - Active, not recruiting
  stage III nasopharyngeal cancer; stage IV nasopharyngeal cancer
  
• A Study of Xeloda (Capecitabine) in Combination With XELOX (Oxaliplatin) in Patients With Metastatic Nasopharyngeal Cancer.
  ClinicalTrials.gov Identifier: NCT00439426 - Active, not recruiting
  Nasopharyngeal Cancer
  
• EBV-Specific CTLs Following CD45 Antibody to Patients with Epstein-Barr Virus (EBV) + Nasopharyngeal Carcinoma (NPC)
  ClinicalTrials.gov Identifier: NCT00078546 - Recruiting
  Nasopharyngeal Cancer; EBV Infections
  
• Swallowing Pattern of Patients With Nasopharyngeal Cancer Before and After Radiation Therapy: Correction With Saliva Amount
  ClinicalTrials.gov Identifier: NCT00173836 - Recruiting
  Nasopharyngeal Carcinoma
  
• A Phase 3 Trial of Adjuvant Chemotherapy in Nasopharyngeal Carcinoma Patients With Residual EBV DNA Following Radiotherapy
  ClinicalTrials.gov Identifier: NCT00370890 - Recruiting
  Nasopharyngeal Cancer
  
• Zileuton in Preventing Lung Cancer in Patients With Bronchial Dysplasia
  ClinicalTrials.gov Identifier: NCT00056004 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Lung Cancer; Nasopharyngeal Cancer; Oropharyngeal Cancer
  
• Gemcitabine and Oxaliplatin (GEMOX) in First Line Metastatic or Recurrent Nasopharyngeal Carcinoma
  ClinicalTrials.gov Identifier: NCT00436800 - Active, not recruiting
  Nasopharyngeal Neoplasms
  
• Oral Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth, Pharynx, or Larynx
  ClinicalTrials.gov Identifier: NCT00004234 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Nasopharyngeal Cancer; oral complications of cancer and cancer therapy; ...
  
• Taxotere + Cisplatin in Nasopharyngeal Carcinoma
  ClinicalTrials.gov Identifier: NCT00436293 - Active, not recruiting
  Nasopharyngeal Neoplasms
  
• Gefitinib, Paclitaxel, and Radiation Therapy in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00083057 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Nasopharyngeal Cancer; Oropharyngeal Cancer; ...
  
• Benefit of Changing Chemoradiotherapy Sequence and Modifying Radiotherapy Schedule for Advanced Nasopharyngeal Cancer
  ClinicalTrials.gov Identifier: NCT00577057 - Not yet recruiting
  Nasopharyngeal Neoplasms
  
• Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00049283 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Nasopharyngeal Cancer; Oropharyngeal Cancer
  
• Carboplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer
  ClinicalTrials.gov Identifier: NCT00003206 - Completed
  recurrent nasopharyngeal cancer; stage IV nasopharyngeal cancer
  
• Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer
  ClinicalTrials.gov Identifier: NCT00274937 - Recruiting
  Nasopharyngeal Cancer; Oral Complications of Chemotherapy and Head and Neck Radiation
  
• Benefit of Adding Chemotherapy for Advance Nasopharyngeal Carcinoma (T1-4N2-3M0)
  ClinicalTrials.gov Identifier: NCT00563927 - Active, not recruiting
  Nasopharyngeal Neoplasms; Carcinoma, Squamous Cell
  
• Molecular Genetics Study of Nasopharyngeal Carcinoma: Characterization of NCP Susceptibility Gene(s)
  ClinicalTrials.gov Identifier: NCT00341146 - Active, not recruiting
  Nasopharyngeal Carcinoma
  
• Combination of Capecitabine and Oxaliplatin in Metastatic Nasopharyngeal Carcinoma
  ClinicalTrials.gov Identifier: NCT00363831 - Recruiting
  Nasopharyngeal Neoplasms
  
• Peptide Vaccine to Prevent Recurrence of Nasopharyngeal Cancer
  ClinicalTrials.gov Identifier: NCT00078494 - Completed
  Nasopharyngeal Neoplasms
  
• Bortezomib and Gemcitabine in Treating Patients With Recurrent or Metastatic Nasopharyngeal Cancer
  ClinicalTrials.gov Identifier: NCT00305734 - Active, not recruiting
  Head and Neck Cancer
  
• RK-0202 in Preventing Oral Mucositis in Patients Who are Undergoing Radiation Therapy for Cancer of the Mouth, Throat, or Salivary Glands
  ClinicalTrials.gov Identifier: NCT00046956 - Recruiting
  lip and oral cavity cancer; Nasopharyngeal Cancer; oral complications of cancer and cancer therapy; Oropharyngeal Cancer; radiation toxicity; ...
  
• Docetaxel in Combination With Cisplatin-5-Fluorouracil for the Induction Treatment of Nasopharyngeal Carcinoma in Children and Adolescents
  ClinicalTrials.gov Identifier: NCT00565448 - Recruiting
  Nasopharyngeal Neoplasms; Carcinoma
  
• Valproic Acid in the Induction of EBV Lytic Cycle Antigen Expression in Nasopharyngeal Carcinoma
  ClinicalTrials.gov Identifier: NCT00181220 - Recruiting
  Nasopharyngeal Carcinoma
  
• Positron Emission Tomography Scanning and Epstein-Barr Virus DNA Levels in the Staging and Follow-Up of Nasopharyngeal Carcinoma.
  ClinicalTrials.gov Identifier: NCT00188253 - Recruiting
  Nasopharyngeal Carcinoma
  
• Therapeutic Gain by Induction-Concurrent Chemoradiotherapy and/or Accelerated Fractionation for Nasopharyngeal Carcinoma
  ClinicalTrials.gov Identifier: NCT00379262 - Recruiting
  Nasopharyngeal Carcinoma
  
• Phase III: Assess Conventional RT w/ Conventional Plus Accelerated Boost RT in the Treatment of Nasopharyngeal CA
  ClinicalTrials.gov Identifier: NCT00535795 - Active, not recruiting
  Nasopharyngeal CA
  
• A Study Of Nasopharyngeal Carcinoma (NPC) Treated With Celecoxib And ZD1839
  ClinicalTrials.gov Identifier: NCT00212108 - Recruiting
  Nasopharyngeal Carcinoma
  
• Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal Carcinoma
  ClinicalTrials.gov Identifier: NCT00431210 - Recruiting
  Nasopharyngeal Carcinoma
  
• Molecular Mechanism of Nasopharyngeal Carcinoma
  ClinicalTrials.gov Identifier: NCT00155181 - Recruiting
  Nasopharyngeal Carcinoma
  
• Defining the Clinical Utility of EBV Antibody Screening to Identify Individuals Susceptible to Nasopharyngeal Carcinoma (NPC) Within High-Risk, Multiplex NPC Families
  ClinicalTrials.gov Identifier: NCT00393224 - Recruiting
  Nasopharyngeal Carcinoma
  
• A Multicenter Trial Comparing Induction C/T Followed by CCRT v.s. CCRT Alone in Stage IV Nasopharyngeal Carcinoma
  ClinicalTrials.gov Identifier: NCT00201396 - Recruiting
  Nasopharyngeal Carcinoma
  
• Pazopanib in Treating Patients With Stage IV or Recurrent Nasopharyngeal Cancer
  ClinicalTrials.gov Identifier: NCT00454142 - Recruiting
  Head and Neck Cancer
  
• Study of High-Dose Chemotherapy with Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis Cancers
  ClinicalTrials.gov Identifier: NCT00141765 - Recruiting
  Wilms Tumor; Fibrosarcoma; Carcinoma, Round Cell; Nasopharyngeal Cancer; Brain Tumor, Recurrent
  
• A Longitudinal Study of Plasma EBV DNA in Nasopharyngeal Carcinoma From Both Endemic and Non-Endemic Patient Populations
  ClinicalTrials.gov Identifier: NCT00186433 - Recruiting
  Lip Cancer; Oral Cancer; Pharynx Cancer
  
• Trial of VELCADE in Patients With Metastatic or Locally Recurrent Nasopharyngeal Carcinoma
  ClinicalTrials.gov Identifier: NCT00367718 - Not yet recruiting
  Nasopharyngeal Carcinoma
  
• Ifosfamide and Doxorubicin in Patients With Refractory Nasopharyngeal Carcinoma
  ClinicalTrials.gov Identifier: NCT00484601 - Recruiting
  Refractory Nasopharyngeal Carcinoma
  
• Intensity Modulated Radiation Therapy for Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00188877 - Recruiting
  Nasopharyngeal Neoplasms
  
• Vorinostat and Azacitidine in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer or Nasal Natural Killer T-Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00336063 - Recruiting
  Head and Neck Cancer; Lymphoma
  
• Whole-Body 18F-FDG PET in Induction Chemotherapeutic Response for Advanced NPC Patients
  ClinicalTrials.gov Identifier: NCT00304694 - Recruiting
  Nasopharyngeal Cancer
  
• Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer
  ClinicalTrials.gov Identifier: NCT00408694 - Recruiting
  Head and Neck Cancer
  
• Celecoxib in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia
  ClinicalTrials.gov Identifier: NCT00101335 - Completed
  Hypopharyngeal Cancer; lip and oral cavity cancer; Nasopharyngeal Cancer; Oropharyngeal Cancer; Precancerous Condition
  
• Acupuncture for Prevention of Radiation-Induced Xerostomia
  ClinicalTrials.gov Identifier: NCT00430378 - Recruiting
  Xerostomia; Mouth Dryness; Nasopharyngeal Cancer
  
• Family Study of Head and Neck Cancers in Taiwan
  ClinicalTrials.gov Identifier: NCT00342147 - Active, not recruiting
  Nasopharyngeal Carcinoma
  
• Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00017511 - Completed
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; metastatic squamous neck cancer with occult primary; Nasopharyngeal Cancer; ...
  
• Lapatinib in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00114283 - Suspended
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Nasopharyngeal Cancer; Oropharyngeal Cancer; ...
  
• Absolute Bioavailability and Nasopharyngeal Absorption of Intranasal Ketamine
  ClinicalTrials.gov Identifier: NCT00520169 - Recruiting
  Healthy
  
• Administration of EBV-Specific Cytotoxic T-Lymphocytes to Patients with EBV-Positive Cancer of the Nose and Throat
  ClinicalTrials.gov Identifier: NCT00074594 - Completed
  Nasopharyngeal Cancer; Epstein-Barr Virus Infections
  
• Study Using Intensity-Modulated Radiation Therapy in Patients with Nasopharyn Cancer to Permit Sparing of Contralateral Parotid Gland Function
  ClinicalTrials.gov Identifier: NCT00123864 - Completed
  Nasopharyngeal Neoplasms
  
• LMP1- and LMP2-Specific CTLs to Patients With EBV-Positive NPC (NATELLA)
  ClinicalTrials.gov Identifier: NCT00516087 - Recruiting
  Nasopharyngeal Carcinoma
  
• Electroacupuncture in Treating Delayed Nausea and Vomiting in Patients Receiving Chemotherapy For Newly Diagnosed Childhood Sarcoma, Neuroblastoma, Nasopharyngeal Cancer, Germ Cell Tumors, or Hodgkin Lymphoma
  ClinicalTrials.gov Identifier: NCT00040911 - Recruiting
  Brain and Central Nervous System Tumors; Childhood Germ Cell Tumor; Extragonadal Germ Cell Tumor; Head and Neck Cancer; Lymphoma; Nausea and Vomiting; ...
  
• LMP1- and LMP2-Specific CTLs Following CD45 Antibody Administration to Patients With EBV-Positive NPC (DELLA)
  ClinicalTrials.gov Identifier: NCT00515957 - Recruiting
  Nasopharyngeal Carcinoma
  
• Treatment Result of KTP Laser Nasopharyngectomy in Recurrent NPC Patients
  ClinicalTrials.gov Identifier: NCT00364962 - Recruiting
  Recurrent; Nasopharyngeal Carcinoma
  
• PHASE III TRIAL COMPARING, NEOADJUVANT CHEMOTHERAPY FOLLOWED BY STANDARD RADIOTHERAPY VERSUS THE SAME NEOADJUVANT CHEMOTHERAPY FOLLOWED BY STANDARD RADIOTHERAPY ASSOCIATED WITH DAILY HYDROXYUREA IN THE TREATMENT OF LOCALLY ADVANCED UNDIFFERENTIATED CARCIN
  ClinicalTrials.gov Identifier: NCT00180973 - Active, not recruiting
  LOCALLY ADVANCED UNDIFFERENTIATED CARCINOMA NASOPHARYNGEAL TYPE UCNT
  
• Zinc Supplements in Lowering Cadmium Levels in Smokers
  ClinicalTrials.gov Identifier: NCT00376987 - Active, not recruiting
  Bladder Cancer; Cervical Cancer; Esophageal Cancer; Gastric Cancer; Head and Neck Cancer; Kidney Cancer; Leukemia; Liver Cancer; Lung Cancer; Pancreatic Cancer; Tobacco Use Disorder
  
• Biological Therapy in Treating Patients With Metastatic Cancer
  ClinicalTrials.gov Identifier: NCT00004604 - Active, not recruiting
  Lung Cancer; Testicular Cancer; ovarian epithelial cancer; Pancreatic Cancer; Colon Cancer; Thyroid Cancer; Gastric Cancer; Salivary Gland Cancer; ...
  
• Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer
  ClinicalTrials.gov Identifier: NCT00287885 - Active, not recruiting
  Cervical Cancer; Endometrial Cancer; Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer; Sarcoma; Vaginal Cancer; Vulvar Cancer
  
• Nasopharyngeal Streptococcus Pneumoniae Carriage
  ClinicalTrials.gov Identifier: NCT00471822 - Recruiting
  Streptococcus Pneumoniae Infections
  
• Gene Therapy in Treating Patients With Cancer
  ClinicalTrials.gov Identifier: NCT00004178 - Active, not recruiting
  Lung Cancer; Pancreatic Cancer; Gastric Cancer; Salivary Gland Cancer; Renal Cell Cancer; Endometrial Cancer; Esophageal Cancer; Head and Neck Cancer; ...
  
• A Phase I Study of ECO-4601 in Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00338026 - Active, not recruiting
  Tumors; Glioma; Colorectal Cancer; Lung Cancer; Breast Cancer; Ovarian Cancer; Pancreatic Cancer; Prostate Cancer
  
• Radiation Therapy With or Without Chemotherapy in Reducing Mouth Dryness in Patients With Nasopharyngeal Cancer
  ClinicalTrials.gov Identifier: NCT00057785 - Active, not recruiting
  oral complications of chemotherapy and head/neck radiation; radiation toxicity; stage I squamous cell carcinoma of the nasopharynx; ...
  
• Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors
  ClinicalTrials.gov Identifier: NCT00433602 - Active, not recruiting
  Breast Cancer; Colorectal Cancer; Gastric Cancer; Lung Cancer; Ovarian Cancer; Pancreatic Cancer; Prostate Cancer; Thromboembolism
  
• Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer
  ClinicalTrials.gov Identifier: NCT00003170 - Active, not recruiting
  Pancreatic Cancer; Vulvar Cancer; Renal Cell Cancer; Endometrial Cancer; Testicular Cancer; ovarian epithelial cancer; Colon Cancer; Rectal Cancer; ...
  
• Study Evaluating the Impact of a 13-Valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Colonization
  ClinicalTrials.gov Identifier: NCT00508742 - Not yet recruiting
  Pneumococcal Infections
  
• Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas
  ClinicalTrials.gov Identifier: NCT00019513 - Active, not recruiting
  Colorectal Cancer; Esophageal Cancer; Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Liver Cancer; Lung Cancer; Lymphoma; Pancreatic Cancer; Small Intestine Cancer; Unspecified Adult Solid Tumor, Protocol Specific
  
• Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients
  ClinicalTrials.gov Identifier: NCT00268918 - Active, not recruiting
  Ovarian Cancer; Endometrial Cancer; Cervical Cancer; Fallopian Tube Cancer; Peritoneal Cancer; Breast Cancer
  
• Phase I Study of SU006668 in Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00024063 - Active, not recruiting
  Lung Cancer; Pancreatic Cancer; Gastric Cancer; Renal Cell Cancer; Colorectal Cancer; Colon Cancer; Prostate Cancer; Rectal Cancer; Breast Cancer; ...
  
• Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer
  ClinicalTrials.gov Identifier: NCT00544193 - Active, not recruiting
  Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Gastric Cancer; Pancreatic Cancer; Small Intestine Cancer
  
• A Phase III Study of Radiotherapy With or Without Adjuvant C/T in Advanced Stage Nasopharyngeal Carcinoma Patients
  ClinicalTrials.gov Identifier: NCT00201344 - Terminated
  Nasopharyngeal Carcinoma
  
• Benefit of Adding Chemotherapy And/Or Modification of Radiotherapy Schedule for Advance Nasopharyngeal Carcinoma (T3-4N0-1M0)
  ClinicalTrials.gov Identifier: NCT00563862 - Terminated
  Nasopharyngeal Neoplasms; Carcinoma, Squamous Cell
  
• Fluorouracil, Cisplatin, and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Nasopharyngeal Cancer
  ClinicalTrials.gov Identifier: NCT00093665 - Active, not recruiting
  stage II lymphoepithelioma of the nasopharynx; stage III lymphoepithelioma of the nasopharynx; stage IV lymphoepithelioma of the nasopharynx; ...
  
• Irinotecan and Capecitabine in Treating Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003867 - Active, not recruiting
  Pancreatic Cancer; Gastric Cancer; Esophageal Cancer; Colorectal Cancer; adult primary liver cancer; Colon Cancer; Rectal Cancer; Breast Cancer
  
• Spectroscopy With Surface Coils and Decoupling
  ClinicalTrials.gov Identifier: NCT00581815 - Recruiting
  Adrenal Cortical Cancer; Brain Cancer; Breast Cancer; CNS Cancer; Colon Cancer; HEENT Cancer; Hodgkin's Disease; Kaposi's Sarcoma; Liver Cancer; Lung Cancer; Non-Hodgkin's Lymphoma; Ovarian Cancer; Pancreatic Cancer; Prostate Cancer; Rectal Cancer; Renal Cancer; Sarcoma; Squamous Cell Carcinoma; Thyroid Cancer
  
• High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00002854 - Active, not recruiting
  Breast Cancer; Gastrointestinal Cancer; Kidney Cancer; Musculoskeletal Cancer; Reproductive Cancer; Skin Cancer
  
• Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer
  ClinicalTrials.gov Identifier: NCT00005049 - Active, not recruiting
  female reproductive cancer; Gastrointestinal Cancer; unclassified and other cancer
  
• Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer
  ClinicalTrials.gov Identifier: NCT00003427 - Active, not recruiting
  Pancreatic Cancer; Colon Cancer; Gastric Cancer; Rectal Cancer; Esophageal Cancer; Colorectal Cancer; adult primary liver cancer
  
• Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium and Decreased Kidney Function
  ClinicalTrials.gov Identifier: NCT00005644 - Active, not recruiting
  Bladder Cancer; Cancer of the Renal Pelvis and Ureter; Gastrointestinal Cancer; Urethral Cancer
  
• Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer
  ClinicalTrials.gov Identifier: NCT00002520 - Active, not recruiting
  Leukemia; Lymphoma; Head and Neck Cancer; Lung Cancer; Eye Cancer; Gastrointestinal Cancer; Oral Cancer; Reproductive Cancer
  
• Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity
  ClinicalTrials.gov Identifier: NCT00003548 - Active, not recruiting
  Gastrointestinal Cancer; Pancreatic Cancer; Liver Cancer; Female Reproductive Cancer
  
• Genetic Study of Patients and Families With a History of Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00003648 - Active, not recruiting
  Colon Cancer; Gastrointestinal Cancer; Rectal Cancer
  
• A Telephone-Based Prevention Care Manager in Increasing Screening Rates for Breast Cancer, Cervical Cancer, and Colorectal Cancer in Minority and Low-Income Women
  ClinicalTrials.gov Identifier: NCT00376909 - Active, not recruiting
  Breast Cancer; Cervical Cancer; Colorectal Cancer
  
• Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction
  ClinicalTrials.gov Identifier: NCT00004910 - Active, not recruiting
  Pancreatic Cancer; Gastric Cancer; Colorectal Cancer; Colon Cancer
  
• Exisulind in Preventing Polyps in Patients With Familial Adenomatous Polyposis
  ClinicalTrials.gov Identifier: NCT00026468 - Active, not recruiting
  Colon Cancer; Rectal Cancer; small intestine cancer
  
• Diet and PSA Levels in Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003367 - Active, not recruiting
  stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate; ...
  
• Conventional Care With or Without Specialized Cancer Care in Treating Patients Receiving Chemotherapy
  ClinicalTrials.gov Identifier: NCT00006253 - Active, not recruiting
  Lung Cancer; Pancreatic Cancer; Endometrial Cancer; Colorectal Cancer; ovarian epithelial cancer; Lymphoma; Colon Cancer; Breast Cancer
  
• Liposomal Lurtotecan in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00022594 - Active, not recruiting
  Neck Cancer; Oral Cancer; Throat Cancer
  
• Celecoxib to Prevent Colorectal Cancer in Patients Who Have Undergone Surgery to Remove Polyps
  ClinicalTrials.gov Identifier: NCT00005094 - Active, not recruiting
  prevention of colorectal cancer; Colon Cancer; Rectal Cancer
  
• Capecitabine Combined with Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00010023 - Active, not recruiting
  Breast Cancer; Gastrointestinal Cancer; Head and Neck Cancer; thorax and respiratory cancer; unclassified and other cancer
  
• Taxotere, Cisplatin and Irinotecan (CPT-11) for Esophagogastric Cancer
  ClinicalTrials.gov Identifier: NCT00165464 - Active, not recruiting
  Esophageal Cancer; Gastric Cancer; GE Junction Cancer
  
• Topotecan in Combination With Pemetrexed in Patients With Advanced Malignancies
  ClinicalTrials.gov Identifier: NCT00315861 - Active, not recruiting
  Ovarian Cancer; Endometrial Cancer; Cervical Cancer; Lung Cancer
  
• Bupropion in Helping Adults Stop Smoking
  ClinicalTrials.gov Identifier: NCT00534001 - Recruiting
  Bladder Cancer; Cervical Cancer; Esophageal Cancer; Gastric Cancer; Head and Neck Cancer; Kidney Cancer; Leukemia; Liver Cancer; Lung Cancer; Pancreatic Cancer; Tobacco Use Disorder
  
• Gemcitabine Combined With Mistletoe in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00049608 - Active, not recruiting
  Breast Cancer; Colorectal Cancer; Lung Cancer; Pancreatic Cancer
  
• Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study
  ClinicalTrials.gov Identifier: NCT00342992 - Active, not recruiting
  Lung Cancer; Prostatic Neoplasms; Prostate Cancer; Pancreatic Cancer
  
• SB-715992 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00095628 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer; paranasal sinus and nasal cavity cancer; ...
  
• Eflornithine Plus Sulindac in Preventing Colorectal Cancer in Patients Who Have Had Surgery to Remove Benign Colorectal Polyps
  ClinicalTrials.gov Identifier: NCT00005882 - Active, not recruiting
  Colon Cancer; Rectal Cancer
  
• Folate-Depleted Diet Compared With Folate-Supplemented Diet in Preventing Colorectal Cancer in Patients at High Risk for Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00096330 - Active, not recruiting
  Colon Cancer; Rectal Cancer
  
• Interleukin-12 in Treating Patients With Cancer in the Abdomen
  ClinicalTrials.gov Identifier: NCT00003046 - Active, not recruiting
  Pancreatic Cancer; Gastric Cancer; Colorectal Cancer; Colon Cancer; Rectal Cancer
  
• Gefitinib in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer That Did Not Respond to Iodine Therapy
  ClinicalTrials.gov Identifier: NCT00095836 - Active, not recruiting
  anaplastic thyroid cancer; follicular thyroid cancer; medullary thyroid cancer; papillary thyroid cancer; Thyroid Cancer
  
• Nitrocamptothecin in Treating Patients With Metastatic Cancer of the Urinary Tract
  ClinicalTrials.gov Identifier: NCT00006026 - Active, not recruiting
  Bladder Cancer; Kidney Cancer; Urethral Cancer